Tau isoform regulation is region‐ and cell‐specific in mouse brain

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The Journal of comparative neurology

• Publication date

  2008-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cne.21867PMID 18925637PMCID PMC2845852
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Knock-out and transgenic mouse models of tauopathies.

  2009cited by this paper
• The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo.

  2007cited by this paper
• Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia.

  2007cited by this paper
• Tau‐4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/ knockout mice

  2007cited by this paper
• The &Dgr;K280 Mutation in MAP tau Favors Exon 10 Skipping In Vivo

  2007cited by this paper
• Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

  2007cited by this paper
• Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease

  2007cited by this paper
• Structural Principles of Tau and the Paired Helical Filaments of Alzheimer’s Disease

  2007cited by this paper
• Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus

  2007cited by this paper
• An improved recombineering approach by adding RecA to λ Red recombination

  2006cited by this paper
• Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex

  2006cited by this paper
• Unexpected abundance of pathological tau in progressive supranuclear palsy white matter

  2006cited by this paper
• Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease

  2006cited by this paper
• An improved recombineering approach by adding RecA to lambda Red recombination.

  2006cited by this paper
• High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.

  2005cited by this paper
• Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms

  2005cited by this paper
• Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death.

  2005cited by this paper
• Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration

  2005cited by this paper
• Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases.

  2005cited by this paper
• Increased Frequency of Argyrophilic Grain Disease in Alzheimer Disease with 4R Tau-Specific Immunohistochemistry

  2005cited by this paper
• The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.

  2005cited by this paper
• Novel haplotypes in 17q21 are associated with progressive supranuclear palsy

  2004cited by this paper
• Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration.

  2004cited by this paper
• Efficacy of doublecortin as a marker to analyse the absolute number anddendritic growth of newly generated neurons in the adult dentate gyrus

  2004cited by this paper
• The structure of the tau haplotype in controls and in progressive supranuclear palsy.

  2004cited by this paper
• Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms

  2003cited by this paper
• Isoforms changes of tau protein during development in various species.

  2003cited by this paper
• Phage annealing proteins promote oligonucleotide-directed mutagenesis in Escherichia coli and mouse ES cells

  2003cited by this paper
• Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies

  2003cited by this paper
• Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease

  2003cited by this paper
• Increased hippocampal neurogenesis in Alzheimer's disease

  2003cited by this paper
• Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

  2003cited by this paper
• The Slow Axonal Transport of the Microtubule-Associated Protein Tau and the Transport Rates of Different Isoforms and Mutants in Cultured Neurons

  2002cited by this paper
• tau Exon 10 Expression Involves a Bipartite Intron 10 Regulatory Sequence and Weak 5′ and 3′ Splice Sites*

  2002cited by this paper
• Sporadic Pick's disease: A tauopathy characterized by a spectrum of pathological τ isoforms in gray and white matter

  2002cited by this paper
• The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies

  2002cited by this paper
• An R5L τ mutation in a subject with a progressive supranuclear palsy phenotype

  2002cited by this paper
• Neurogenesis in Adult Mammals: Some Progress and Problems

  2002cited by this paper
• Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

  2001cited by this paper
• Axonal Tau mRNA Localization Coincides with Tau Protein in Living Neuronal Cells and Depends on Axonal Targeting Signal

  2001cited by this paper
• Phenotypic correlations in FTDP-17.

  2001cited by this paper
• Competition for microtubule-binding with dual expression of tau missense and splice isoforms.

  2001cited by this paper
• Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces.

  2001cited by this paper
• Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy

  2001cited by this paper
• A genomic sequence analysis of the mouse and human microtubule-associated protein tau

  2001cited by this paper
• Tau and transgenic animal models.

  2001cited by this paper
• Neurodegenerative tauopathies.

  2001cited by this paper
• TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam.

  2001cited by this paper
• Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

  2001cited by this paper
• Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

  2000cited by this paper
• Determinants of 4-Repeat Tau Expression

  2000cited by this paper
• Single-step conversion of P1 and P1 artificial chromosome clones into yeast artificial chromosomes.

  2000cited by this paper
• Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene

  2000cited by this paper
• Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.

  2000cited by this paper
• Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy

  2000cited by this paper
• Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

  2000cited by this paper
• Structural and Functional Differences between 3-Repeat and 4-Repeat Tau Isoforms

  2000cited by this paper
• An extended 5′-tau susceptibility haplotype in progressive supranuclear palsy

  2000cited by this paper
• Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease

  1999cited by this paper
• Rapid modification of bacterial artificial chromosomes by ET-recombination.

  1999cited by this paper
• Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

  1999cited by this paper
• Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

  1999cited by this paper
• Rapid treadmilling of brain microtubules free of microtubule-associated proteins in vitro and its suppression by tau.

  1999cited by this paper
• 5′ Splice Site Mutations in tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10*

  1999cited by this paper
• Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders.

  1999cited by this paper
• Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

  1999cited by this paper
• A new logic for DNA engineering using recombination in Escherichia coli

  1998cited by this paper
• Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.

  1998cited by this paper
• Tau is a candidate gene for chromosome 17 frontotemporal dementia

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

  1998cited by this paper
• Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly.

  1997cited by this paper
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform.

  1995cited by this paper
• Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.

  1995cited by this paper
• Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau.

  1994cited by this paper
• Domains of tau protein and interactions with microtubules.

  1994cited by this paper
• Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau

  1994cited by this paper
• Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists.

  1993cited by this paper
• Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala

  1992cited by this paper
• Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system.

  1992cited by this paper
• Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

  1992cited by this paper
• Blood groups of the Cantabrian population (Spain).

  1992cited by this paper
• Tau protein binds to microtubules through a flexible array of distributed weak sites

  1991cited by this paper
• Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

  1990cited by this paper
• Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

  1989cited by this paper
• Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

  1989influential reference
• The microtubule binding domain of tau protein.

  1989cited by this paper
• Developmentally regulated expression of specific tau sequences.

  1989cited by this paper
• Epitopes that span the tau molecule are shared with paired helical filaments.

  1988cited by this paper

• CELF2 Promotes Tau Exon 10 Inclusion via Hinge Domain-Mediated Nuclear Condensation, Driving Cognitive Dysfunction in Tauopathy Models

  2026cites this paper
• Spontaneous tauopathy with parkinsonism in an aged cynomolgus macaque

  2026cites this paper
• Cryo-EM structure of pro-aggregant P301L/S320F double-mutant tau filaments formed in mouse brains following peripheral AAV delivery

  2026cites this paper
• Differential effects of tau expression on seizures and epileptogenesis in a mouse model of temporal lobe epilepsy

  2025cites this paper
• Scalable human neuronal models of tauopathy producing endogenous seed-competent 4R tau

  2025cites this paper
• Tau deletion results in sex-dependent modulation of synaptic weakening in rat hippocampus

  2025cites this paper
• Twenty years of therapeutic development in tauopathy mouse models: a scoping review

  2025cites this paper
• Exercise Improves Alzheimer’s Disease Phenotype in the TgF344-AD Rat, a Behavioral Time Course Study of Males and Females

  2025cites this paper
• Telomere-driven senescence accelerates tau pathology, neuroinflammation and neurodegeneration in a tauopathy mouse model

  2025cites this paper
• Cellular and molecular mechanisms of pathological tau phosphorylation in traumatic brain injury: implications for chronic traumatic encephalopathy

  2025cites this paper
• Seed structure and phosphorylation in the fuzzy coat impact tau seeding competency

  2025cites this paper
• Excessive Alcohol Use as a Risk Factor for Alzheimer's Disease: Epidemiological and Preclinical Evidence.

  2025cites this paper
• Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research

  2025influential citation
• 4R-tau isoform induction via TDP-43 in neurons in response to insulin: converging signaling pathways with implications for neurodegenerative disease

  2025cites this paper
• Genetically modified non-human primate models for research on neurodegenerative diseases

  2024cites this paper
• The role of microtubule-associated protein tau in netrin-1 attractive signaling.

  2024cites this paper
• Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases

  2024cites this paper
• CELF2 promotes tau exon 10 inclusion via hinge domain-mediated nuclear condensation

  2024cites this paper
• Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models.

  2024cites this paper
• Analysis of early effects of human APOE isoforms on Alzheimer’s disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE

  2024cites this paper
• Long-read RNA sequencing identifies region- and sex-specific C57BL/6J mouse brain mRNA isoform expression and usage

  2024cites this paper
• Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry

  2024cites this paper
• The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes

  2024cites this paper
• Synaptopathy: presynaptic convergence in frontotemporal dementia and amyotrophic lateral sclerosis

  2024cites this paper
• Diverse Efficacy of Dimethyl Fumarate in Alleviating the Late Streptozotocin-Induced Cognitive Impairment and Neuropathological Features in Rat

  2024cites this paper
• Long-read RNA sequencing identifies region- and sex-specific C57BL/6J mouse brain mRNA isoform expression and usage

  2024cites this paper
• Transfixed by transgenics: how pathology assumptions are slowing progress in Alzheimer's disease and related dementia research

  2023cites this paper
• Expression of tau and phosphorylated tau in the brain of normal and hemiparkinsonian rhesus macaques

  2023cites this paper
• Deregulated Transcription and Proteostasis in Adult mapt Knockout Mouse

  2023cites this paper
• Tau protein plays a role in the mechanism of cognitive disorders induced by anesthetic drugs

  2023cites this paper
• Tau expression and phosphorylation in enteroendocrine cells

  2023cites this paper
• A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice

  2023influential citation
• Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies.

  2023cites this paper
• Mice in translational neuroscience: What R we doing?

  2022cites this paper
• Reassessment of Neuronal Tau Distribution in Adult Human Brain and Implications for Tau Pathobiology

  2022cites this paper
• Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology

  2022cites this paper
• Differences in Tau Seeding in Newborn and Adult Wild-Type Mice

  2022cites this paper
• The TgF344-AD rat: behavioral and proteomic changes associated with aging and protein expression in a transgenic rat model of Alzheimer's disease.

  2022cites this paper
• Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the Aβ-coding region of App

  2022cites this paper
• Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock- in rats with humanizing mutations in the Aβ-coding region of App

  2022cites this paper
• Differential Effects of Human Tau Isoforms to Neuronal Dysfunction and Toxicity in the Drosophila CNS

  2022cites this paper
• Tau interactome and RNA binding proteins in neurodegenerative diseases

  2022cites this paper
• Targeting Microtubule-Associated Protein Tau in Chemotherapy-Resistant Models of High-Grade Serous Ovarian Carcinoma

  2022cites this paper
• Differential Effects of the Six Human TAU Isoforms: Somatic Retention of 2N-TAU and Increased Microtubule Number Induced by 4R-TAU

  2021cites this paper
• Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease

  2021cites this paper
• GSK-3 and Tau: A Key Duet in Alzheimer’s Disease

  2021cites this paper
• Tau Isoform-Driven CBD Pathology Transmission in Oligodendrocytes in Humanized Tau Mice

  2021cites this paper
• Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits

  2021cites this paper
• Hydrogen sulfide is neuroprotective in Alzheimer’s disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation

  2021cites this paper
• A Review of the Current Mammalian Models of Alzheimer’s Disease and Challenges That Need to Be Overcome

  2021cites this paper
• Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease

  2021cites this paper
• Host Tau Genotype Specifically Regulates and Designs Tau Seeding and Spreading Following Intracerebral Injection of Identical Tau ADInoculum

  2021cites this paper
• Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate

  2021cites this paper
• Current directions in tau research: Highlights from Tau 2020

  2021cites this paper
• A familial Danish dementia rat shows impaired presynaptic and postsynaptic glutamatergic transmission

  2021cites this paper
• Tau Exon 10 Inclusion by PrPC through Downregulating GSK3β Activity

  2021cites this paper
• In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics

  2021cites this paper
• A model of traumatic brain injury using human iPSC-derived cortical brain organoids

  2020cites this paper
• Relevance of host tau in tau seeding and spreading in tauopathies

  2020cites this paper
• Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice

  2020influential citation
• Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy

  2020cites this paper
• The effects of mild closed head injuries on tauopathy and cognitive deficits in rodents: Primary results in wild type and rTg4510 mice, and a systematic review.

  2020cites this paper
• Intracerebral seeding of amyloid-β and tau pathology in mice: factors underlying prion-like spreading and comparisons with α-synuclein.

  2020cites this paper
• Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease

  2020cites this paper
• Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation

  2020cites this paper
• Tau Reduction Prevents Key Features of Autism in Mouse Models.

  2020cites this paper
• Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy

  2020cites this paper
• Capacity for Seeding and Spreading of Argyrophilic Grain Disease in a Wild-Type Murine Model; Comparisons With Primary Age-Related Tauopathy

  2020cites this paper
• Tau modulates visual plasticity in adult and old mice.

  2020cites this paper
• The effect of insomnia on development of Alzheimer’s disease

  2020cites this paper
• Cellular Biology of Tau Diversity and Pathogenic Conformers

  2020cites this paper
• Transmission of tauopathy strains is independent of their isoform composition

  2020cites this paper
• Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model.

  2019cites this paper
• An evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer's disease.

  2019cites this paper
• Minimalistic in vitro systems for investigating tau pathology.

  2019cites this paper
• The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?

  2019cites this paper
• Tau isoform expression and phosphorylation in marmoset brains

  2019cites this paper
• Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein

  2019cites this paper
• Overview of Transgenic Mouse Models for Alzheimer's Disease

  2019cites this paper
• The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD)

  2019cites this paper
• Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer’s disease

  2019cites this paper
• Disease-modifying strategies in primary tauopathies.

  2019cites this paper
• Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases

  2019cites this paper
• Co-Expression of Three Wild-Type 3R-Tau Isoforms Induces Memory Deficit via Oxidation-Related DNA Damage and Cell Death: A Promising Model for Tauopathies

  2019cites this paper
• LITHUANIAN UNIVERSITY OF HEALTH SCIENCES

  2019cites this paper
• Systematic evaluation of isoform function in literature reports of alternative splicing

  2018cites this paper
• Generation of a New Tau Knockout (tauΔex1) Line Using CRISPR/Cas9 Genome Editing in Mice

  2018cites this paper
• Hippocampal place cell dysfunction and the effects of muscarinic M1 receptor agonism in a rat model of Alzheimer's disease

  2018cites this paper
• A liquid chromatography tandem mass spectroscopy approach for quantification of protein methylation stoichiometry.

  2018influential citation
• Novel monoclonal antibodies targeting the microtubule-binding domain of human tau

  2018cites this paper
• Investigating the Role of Glycogen Synthase Kinase-3 (GSK-3) in Pathological Progression of Alzheimer’s Disease

  2018cites this paper
• Tau ablation in mice leads to pancreatic β cell dysfunction and glucose intolerance

  2018influential citation
• A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies

  2018cites this paper
• Tauopathy in the APPswe/PS1ΔE9 mouse model of familial Alzheimer’s disease

  2018cites this paper
• FTDP-17 Mutations Alter the Aggregation and Microtubule Stabilization Propensity of Tau in an Isoform-Specific Fashion.

  2018cites this paper
• Chronic traumatic encephalopathy‐integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology

  2017cites this paper
• Systemic and network functions of the microtubule‐associated protein tau: Implications for tau‐based therapies

  2017cites this paper
• Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.

  2017cites this paper
• Rodent Models for Alzheimer’s Disease in Drug Discovery

  2017cites this paper
• Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.

  2017cites this paper